Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma

scientific article published on 6 January 2005

Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1002/CNCR.20757
P698PubMed publication ID15637696

P50authorDiana GiannarelliQ44736865
Emilio BriaQ46978152
P2093author name stringFrancesco Cognetti
Alessandra Felici
Cecilia Nisticò
Edmondo Terzoli
Barbara Vanni
Federica Cuppone
William P Peters
P2860cites workTaxane containing regimens for metastatic breast cancerQ24248042
Meta-analysis of the literature or of individual patient data: is there a difference?Q34334544
Meta-analyses of randomised clinical trials in oncology.Q34571922
Confronting publication bias: a cohort design for meta-analysisQ39771536
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial.Q40606333
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial.Q44362096
Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality.Q47252460
Interpreting Measures of Treatment Effect in Cancer Clinical TrialsQ56020813
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III TrialQ64112043
Sequential single-agent chemotherapy for metastatic breast cancer: therapeutic nihilism or realism?Q72999286
Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancerQ73384968
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 womenQ77435888
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectbreast carcinomaQ18555947
P304page(s)672-679
P577publication date2005-02-01
P1433published inCancerQ326041
P1476titleTaxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma
P478volume103